Trial Profile
Vyvanse and Glucose Intolerance in Children With ADHD and Obesity.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacodynamics
- 16 Nov 2012 Actual end date (Aug 2012) added as reported by ClinicalTrials.gov.
- 12 Jun 2011 Planned end date changed from 1 May 2011 to 1 May 2012 as reported by ClinicalTrials.gov.
- 12 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.